Stacy Zamudio, PhD

Stacy-1Senior Scientist , Director of Research, Department of Obstetrics and Gynecology

Academic Title: Adjunct Associate Professor of Preventive Medicine and Community Health UMDNJ-New Jersey Medical School

Education: B.A., M.A., University of California, Los Angeles, Ph.D. University of Colorado, Boulder 

Dr. Zamudio has published over 60 articles on maternal and fetal physiology,  genetics, epidemiology, and clinical outcomes. She studies what goes wrong with the placenta in pregnancies with complications like placenta accreta and preeclampsia. Her work has been funded by the National Institutes of Health (NIH), the National Science Foundation, the American Heart Association and the Fogarty International Research Collaborative. She is a leader in the field, serving on 3 scientific journal editorial boards, as President of the Perinatal Research Society and as Chair of the NIH Obstetrics and Maternal-Fetal Biology study section (OMFB). OMFB evaluates training grants in reproductive biology/medicine, clinical trials, and transition to independence award for junior faculty. In this capacity Dr. Zamudio helps to shape the future of research in obstetrics and gynecology and the next generation of scientists. 

She currently holds NIH funding to study how the placental genome has evolved to protect fetuses from the adverse effects of hypoxia (lack of oxygen), a common feature in pregnancy complications. Her work on placenta accreta has several goals: to develop a diagnostic test that can be used early in pregnancy, to improve our ability to discriminate between mild, moderate and severe disease via diagnostic imaging, and to learn how the cells of the placenta are permitted to invade tissues they normally do not invade.


Nicholas P. Illsley, D.Phil.

Nick-1Senior Scientist, Department of Obstetrics and Gynecology

Academic Title:  Adjunct Professor of Pharmacology and Physiology, UMDNJ-New Jersey Medical School

Education:  B.Sc. (Hons) in Biochemistry, University of Bristol, U.K., D.Phil., University of Oxford, U.K.

Dr. Illsley moved to HUMC recently, following positions at the U.K. Medical Research Council’s Clinical Research Centre in London, the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California San Francisco and the Department of Obstetrics, Gynecology and Women’s Health at UMDNJ-New Jersey Medical School. His research focuses on the human placenta, its mechanisms of maternal to fetal transport, its metabolism and its role in the regulation of fetal growth. He has studied diabetic pregnancy, fetal growth restriction, preeclampsia and pregnancies subject to chronic hypoxia. He has published more than 75 articles in scientific journals. He has been awarded multiple research grants primarily from the National Institutes of Health (NIH), with continuous funding since 1988. He currently holds an NIH grant designed to develop a mouse model for investigations of hypoxia in pregnancy.

Dr. Illsley is a leader in his field, helping to found both the Placenta Association of the Americas for which he served as the first President (2001-2011) and the International Federation of Placenta Associations for which he has just been elected President. He has served on editorial boards and on the Councils of the Society for Gynecologic Investigation and Perinatal Research Society. He was a member of the NIH Human Embryology and Development Study Section and continues to serve on multiple NIH study sections, reviewing research in perinatal medicine. Dr. Illsley has now put this experience and expertise to use in a new role, leading investigations for the Center for Abnormal Placentation.

close (X)